A therosclerosis is a multifactorial disease developing over many years, with symptoms becoming apparent in the late stages of the disease. Inflammation, 1 oxidative stress, 2 and endothelial dysfunction 3 are associated with the pathogenesis of atherosclerosis. Polyphenols are naturally occurring components of fruits and vegetables and are currently the focus of much nutritional and therapeutic interest. The results of population studies suggest that adopting polyphenol-rich diets may protect against cardiovascular disease, 4 -6 whereas animal and human intervention studies indicate cardiovascular protective effects of polyphenol-rich foods. [7] [8] [9] [10] [11] Mechanisms by which these compounds exert their cardiovascular protective effects are inconclusive. It is widely hypothesized that dietary polyphenols protect against atherosclerosis by preventing 1 or more of the processes involved in disease progression, such as oxidative stress, inflammation, and endothelial dysfunction. 12 However, there are many hundreds of polyphenols in the human diet, and it is not yet known if some compounds offer more cardiovascular protection than others.
We selected several common dietary polyphenols (structures in Figure 1 ), such as quercetin (a flavonol found in the diet from fruits, vegetables, and tea), (Ϫ)-epicatechin (a flavan-3-ol from cocoa and tea), theaflavin (a dimeric catechin from black tea), sesamin (a lignan from sesame seeds), and chlorogenic acid (a phenolic acid from coffee and some fruits) for this study. Grape polyphenols (including quercetin) have been shown to improve the lipoprotein profile and reduce plasma inflammatory biomarkers and oxidized lowdensity lipoprotein (LDL) in healthy human subjects, which may decrease cardiovascular disease risk. 7, 8 Quercetin reduces blood pressure and improves endothelial function in the rat. 13 Previous human intervention studies have indicated that (Ϫ)-epicatechin from cocoa improves endothelial function 9 and reduces inflammation. 10 In a short-term human intervention study, we demonstrated that quercetin and, to a lesser extent, (Ϫ)-epicatechin are able to augment NO production and reduce endothelin-1 (ET-1), whereas epigallocatechin gallate had no effect. 14 In vitro studies with leukocytes indicate that the anti-inflammatory activity of flavonoids may be dissociated from their antioxidant activity. 15 Theaflavin was included in our study because it is a major constituent of black tea, which is widely consumed in Western countries and may offer similar antioxidant potency as green tea catechins. 16 Black tea consumption has been shown to improve endothelial function in patients with coronary artery disease. 11 Sesamin is a bioactive lignan in sesame seeds; it was shown to reduce LDL cholesterol and interfere with the metabolism of the antioxidant ␥-tocopherol. 17 Chlorogenic acid, a major component of coffee and some fruits, can act as an antioxidant in vitro. 18 Given concerns about the bioavailability of polyphenols in vivo, 19 we examined their effects when incorporated individually into the diet of a wellestablished mouse model of atherosclerosis. We determined if these pure polyphenols prevent or reduce the formation of atherosclerotic lesions in apolipoprotein E (ApoE) Ϫ/Ϫ mice and investigated the mechanisms by which these compounds may exert their antiatherosclerotic effects. This study provides insight into the potential beneficial effects of consuming polyphenol-rich diets.
Methods

Materials
Chemicals and reagents were purchased from Sigma Aldrich, St Louis, Mo; and Cayman Chemical, Ann Arbor, Mich. High-purity solvents were from Univar (Perth, Western Australia). Sesamin and theaflavin were provided by Suntory (Japan) and Unilever (Netherlands), respectively. All compounds had greater than 95% purity based on high-performance liquid chromatographic analysis.
C57BL/6J and ApoE
؊/؊ Mice
The present study was approved by and performed under the guidelines of the Animal Ethics Committees of the University of Western Australia and Royal Perth Hospital. A total of 150 fourweek-old male ApoE Ϫ/Ϫ mice and 25 C57BL/6J mice were obtained from the Animal Resource Centre, Canningvale, Australia. The genetic background for the ApoE Ϫ/Ϫ is C57BL/6J. They have been backcrossed to the C57BL/6J 10 times. The mice were housed in groups of 5 and placed on a nonpurified stock diet of AIN, 93 mol/L (Glenforrest Stockfeeds, Perth, Western Australia) (calculated nutritional parameters in Supplemental Table 1 ; available online at http://atvb.ahajournals.org). A total of 125 ApoE Ϫ/Ϫ mice were randomized to receive quercetin, (Ϫ)-epicatechin, theaflavin, sesamin, or chlorogenic acid (1.3 mg/d; 64-mg/ kg body mass; nϭ25 for each treatment group). These levels are approximately equivalent to 350 mg/d in humans. 20 The treatment compounds were blended with the mouse feed, which was ground into pellets and stored at 0°C until used. The control groups of 25 ApoE Ϫ/Ϫ mice and 25 C57BL/6J wild-type mice received the blended and pelletized mouse feed with no compounds added. The mice began to receive the prescribed treatment at the age of 6 weeks, until the end of the study. Food, fluid intake, and body weight were monitored on a regular basis throughout the study. Urine was collected from each group in metabolic cages at the ages of 16 and 26 weeks. After 10 weeks of treatment, when the mice were aged 16 weeks, 5 from each group were killed for analysis of early lesion development and plasma and aortic biochemistry studies. The remaining mice were killed for the same analyses at the age of 26 weeks (ie, after 20 weeks of treatment). Animal numbers were based on the power analysis performed on the desired end points (PϽ0.008 for multiple comparisons between the treatment and control groups) and on a previous study that showed significant differences in lesion area by the age of 26 weeks. 21 
Plasma and Aortic Tissue Sampling
Nonfasting mice from each group were studied at the ages of 16 weeks (nϭ5) and 26 weeks (nϭ20). Mice were anesthetized with pentobarbital sodium (Nembutal), and the abdominal and thoracic cavities were opened by ventral incision. A blood sample was obtained via vena cava puncture and collected into 50-L EDTA, 1 g/10 mL in 0.9% saline. The blood plasma was stored after the addition of butylated hydroxytoluene, 8 g/mL, at Ϫ80°C. The aortic sinus and the thoracic and abdominal aorta were removed and stripped of any external fatty deposits. Aortas for histopathologic and biochemical analysis were prepared as previously described. 21, 22 
Histological Analysis of Mouse Aorta Specimens
The size of atherosclerotic lesions in the mouse aorta was determined by measuring the cross-sectional lesion area using procedures described previously. 22 The aorta was rinsed in phosphate-buffered saline (PBS) after removal from the phosphate-buffered formaldehyde (4% by volume; pH, 7.0 to 7.3) and processed as described in the Supplemental Material. For immunohistochemistry of heme oxygenase-1 (HO-1), paraffin-embedded thoracic aorta specimens were sectioned every 400 m, proximally from the third pair of intercostal arteries, for a total distance of 2800 m. HO-1 protein was detected with anti-rat HO-1 polyclonal rabbit antibody (SPA-895; Stressgen, Ann Arbor, Mich) (final concentration, 10 g/mL), applied for 24 hours at 4°C. Bound HO-1 antibody was detected with biotinylated anti-rabbit goat IgG (Dako, Glostrup, Denmark) (final concentration, 3.8 g/mL), applied for 1 hour at room temperature, and the ABC detection method (Vectastain Elite ABC kit; Vector Laboratories, Burlingame, Calif). Counterstaining was achieved with hematoxylin and Scott blue solution. 
Plasma Cholesterol and Aortic Fatty Acid Composition
The total cholesterol content of the mouse plasma samples was measured using a commercially available cholesterol assay kit (Boehringer Mannheim, Germany). Aortic tissue was thawed, weighed, and homogenized in 2 mL of PBS and extracted using ice-cold Folch solution (chloroform-methanol, 2:1 by volume containing 0.1-mmol/L butylated hydroxytoluene). The chloroform layer (containing the F 2 -isoprostanes and fatty acids) was collected, dried, and analyzed, as described in detail in the Supplemental Material. For the distribution of lipoprotein classes, mouse plasma was fractionated by fast protein liquid chromatography using 2 columns (Superose HR6 10/30; Amersham Biosciences, Uppsala, Sweden) in series at a flow rate of 30 mL/h. Plasma samples from 5 mice in the same group (80 L each) were pooled to give 400 L, were diluted with 400 L of PBS, and were filtered through a 0.45-m filter; 450 L of diluted plasma was applied to the column and eluted with PBS containing 1-mmol/L EDTA (pH, 7.2). Fractions, 0.5 mL, were collected into tubes containing butylated hydroxytoluene, 20 L, at 4 mg/mL. Protein was monitored continuously by absorbance at 280 nm, and total cholesterol was measured in each of the fractions using an enzymatic method (Roche Diagnostics GmbH, Mannheim, Germany).
Oxidative Stress
Vascular oxidative stress was assessed by measuring F 2 -isoprostanes in aortic tissue by gas chromatography-mass spectrometry using a previously described method. 23 Aortic F 2 -isoprostanes were measured in lipid extracts from the mouse aortas and corrected for arachidonic acid. Vascular superoxide was assessed by lucigeninderived chemiluminescence, 24 as described in detail in the Supplemental Material. The chemiluminescence signal was inhibited by 90% in control incubations, with superoxide dismutase added.
Ex Vivo Vascular Leukotriene B 4 Production
The effect of the polyphenol treatments on 5-lipoxygenase enzyme activity was determined by measuring vascular leukotriene B 4 (LTB 4 ) production ex vivo, as described in detail in the Supplemental Material.
Plasma-Soluble P-Selectin
The long-term effects of treatment on platelet reactivity were investigated by measuring the plasma concentrations of soluble P-selectin (sP-selectin) using a commercially available mouse sPselectin enzyme immunoassay kit (R&D Systems, Minneapolis, Minn).
Vascular Endothelial NO Synthase Activity, Urinary Nitrite, Nitrate, and ET-1 NOS activity in aortic homogenates was determined by monitoring the conversion of L-
]citrulline using an NOS activity assay kit (Cayman Chemical). Results were expressed as picomoles of L-citrulline per milligram of protein per 60 minutes. Nitrite and nitrate concentrations in urine were determined using a previously published gas chromatographic-mass spectrometric method. 25 Results were corrected for creatinine levels. ET-1 was measured in urine with a commercially available ET-1 (mouse) enzyme immunoassay kit (Assay Design, Ann Arbor, Mich). ET-1 concentrations were corrected for creatinine levels.
Statistical Analysis
Statistical analyses were performed using SPSS version 15 (SPSS Inc, Chicago, Ill). Data are presented as meanϮSEM. A 1-way ANOVA 26 with post hoc analyses using the Tukey honestly significant difference test was used to compare treatments. Initially, the ApoE Ϫ/Ϫ control mice were compared with the C57BL/6J mice. The effect of polyphenol treatments in the ApoE Ϫ/Ϫ mice were then compared with effects in the ApoE Ϫ/Ϫ control mice. The results analyzed were considered significantly different when PϽ0.05.
Results
Animals and Polyphenol Diets
There was no difference in body mass between C57BL/6J and ApoE Ϫ/Ϫ mice over 26 weeks (from a mean body mass of 9.5Ϯ 0.5 g at week 4 to 28.0Ϯ0.3 g at week 26). The daily intake of the polyphenols was calculated for each group based on the daily consumption of the mouse feed (mean daily intake in mg/kg of body mass: quercetin, 63.8Ϯ0.5; (Ϫ)-epicatechin, 64.0Ϯ0.3; theaflavin, 63.5Ϯ0.8; sesamin, 63.7Ϯ0.4; and chlorogenic acid, 63.8Ϯ0.6). No significant difference between the groups was observed.
Aortic Lesion Analyses
The lesion area in the transverse section of the aorta was expressed as a percentage of the lesion to the total area of the aortic tissue. No significant atherosclerotic lesion was observed in C57BL/6J and ApoE Ϫ/Ϫ mice at the age of 16 weeks (data not shown). At the age of 26 weeks, ApoE Ϫ/Ϫ mice exhibited significantly greater lesions at the aortic sinus and the thoracic aortic region just below the aortic arch compared with the C57BL/6J control mice (Figure 2A and B; PϽ0.05 versus C57BL/6J mice). Lesion formation at both locations was significantly reduced in ApoE Ϫ/Ϫ mice fed a diet containing quercetin or theaflavin (Figure 2A and B, 60% to 80% and 45% to 55%, respectively; PϽ0.05 versus ApoE Ϫ/Ϫ control mice). Examples of micrographs for aortic cross sections stained for lipid lesions are shown in Supplemental Figure I (available online at http://atvb.ahajournals. org). Treatment with (Ϫ)-epicatechin, sesamin, and chlorogenic acid appeared to diminish lesion formation (14%, 40%, and 29%, respectively, versus ApoE Ϫ/Ϫ mice); however, these differences were not statistically significant.
In a subgroup of mice, the expression of HO-1 protein in aortic sections was examined. Aortic sections from apoE Ϫ/Ϫ mice showed greater staining for HO-1 than those of C57BL/6J mice, with HO-1 staining limited largely to atherosclerotic lesions. In apoE Ϫ/Ϫ mice fed the quercetinsupplemented diet, HO-1 protein was significantly increased compared with either the apoE Ϫ/Ϫ control (PϽ0.05) or the epicatechin-fed apoE Ϫ/Ϫ mice (PϽ0.01) (Figure 3 ).
Plasma Cholesterol and Aortic Fatty Acid Composition
ApoE Ϫ/Ϫ mice had significantly elevated plasma concentrations of cholesterol compared with the C57BL/6J mice (Supplemental Table II ). The polyphenols did not significantly affect plasma cholesterol concentrations or lipoprotein distribution (Supplemental Figure II) in the ApoE Ϫ/Ϫ mice after 20 weeks of treatment. None of the polyphenol treatment exerted a significant effect on the fatty acid composition in the aorta compared with the control apoE Ϫ/Ϫ mice (data not shown).
Vascular Oxidative Stress
At the age of 26 weeks, ApoE Ϫ/Ϫ mice had significantly higher concentrations of aortic F 2 -isoprostanes than C57BL/6J mice ( Figure 4A, PϽ0.05 ). Diets incorporating quercetin or (Ϫ)-epicatechin significantly reduced aortic F 2 -isoprostane concentrations in ApoE Ϫ/Ϫ mice ( Figure 4A ,
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PϽ0.05 versus ApoE Ϫ/Ϫ control mice). Theaflavin, sesamin, and chlorogenic acid treatments did not show any significant effect on aortic F 2 -isoprostane concentrations. Aortic tissues from the ApoE Ϫ/Ϫ mice had a slightly elevated superoxide level compared with C57BL/6J mice at the age of 26 weeks ( Figure 4B ), although this was not significantly different. Quercetin and (Ϫ)-epicatechin treatments significantly attenuated vascular superoxide ( Figure 4B , PϽ0.05 versus ApoE Ϫ/Ϫ control mice); no significant effect was observed for the other treatments.
Ex Vivo Vascular LTB 4 Production and Plasma-sP-Selectin
Aortic tissues from ApoE Ϫ/Ϫ mice produced significantly higher amounts of LTB 4 compared with the C57BL/6J mice ( Figure 4C, PϽ0.05 ). Quercetin and theaflavin treatment significantly reduced LTB 4 in the aortic tissues ( Figure 4C, 
PϽ0.05).
ApoE Ϫ/Ϫ mice expressed significantly higher plasma concentrations of sP-selectin than C57BL/6J mice at the age of 26 weeks (PϽ0.005) ( Figure 4D ). Treatment with quercetin, (Ϫ)-epicatechin, and theaflavin significantly lowered the plasma sP-selectin concentrations (PϽ0.005 versus ApoE Ϫ/Ϫ control mice). Sesamin and chlorogenic acid did not significantly affect plasma sP-selectin concentrations compared with the ApoE Ϫ/Ϫ control mice ( Figure 4D ). A, Cross-sectional lesion area (percentage of total cross-sectional area) in the aortic sinus from C57BL and ApoE Ϫ/Ϫ mice after 20 weeks of different dietary treatments: C57BL/ control (nϭ20), ApoE/control (nϭ20), ApoE/quercetin (nϭ18), ApoE/(Ϫ)-epicatechin (nϭ19), ApoE/theaflavin (nϭ20), ApoE/sesamin (nϭ18), and ApoE/chlorogenic acid (nϭ19). B, Cross-sectional lesion area (percentage of total cross-sectional area) in the thoracic region just below the aortic arch from C57BL and ApoE Ϫ/Ϫ mice after 20 weeks of different dietary treatments: C57BL/control (nϭ20), ApoE/control (nϭ20), ApoE/ quercetin (nϭ18), ApoE/(Ϫ)-epicatechin (nϭ19), ApoE/theaflavin (nϭ20), ApoE/sesamin (nϭ18), and ApoE/chlorogenic acid (nϭ19). In A and B, bars with the same subscript are not significantly different from each other using 1-way ANOVA analysis with the Tukey honestly significant difference post hoc analysis. 
Vascular Endothelial NO Synthase Activity and Urinary Nitrite, Nitrate, and ET-1
At the age of 26 weeks, the vascular endothelial NO synthase (eNOS) activity of ApoE Ϫ/Ϫ mice in the control group was significantly lower compared with the C57BL/6J mice (PϽ0.05, Figure 5A ). Quercetin and theaflavin significantly increased eNOS activity in the aortic tissues (PϽ0.05 versus ApoE Ϫ/Ϫ control mice, Figure 5A ), whereas the other polyphenols showed insignificant elevations in eNOS activity. The increase in eNOS activity significantly correlated with the elevation in excretion of nitrate in the polyphenol-treated ApoE Ϫ/Ϫ mice at 26 weeks (Rϭ0.65, PϽ0.001). All 5 treatments elevated the urinary nitrate concentration, with quercetin-or theaflavin-treated ApoE Ϫ/Ϫ mice having significantly higher urinary nitrate concentrations compared with the ApoE Ϫ/Ϫ control mice (PϽ0.05, Supplemental Table III ). However, there was no significant difference in urinary nitrite between any of the treatment groups (Supplemental Table III) .
Urinary concentrations of ET-1 were significantly increased in the ApoE Ϫ/Ϫ mice at the age of 26 weeks compared with C57BL/6J mice (PϽ0.05); this was attenuated with quercetin and (Ϫ)-epicatechin dietary treatments (PϽ0.05, Figure 5B ).
Correlation Between Lesion Size and Biomarkers
Lesion size at the aortic sinus was significantly correlated with aortic F 2 -isoprostanes (Rϭ0. 29 Table IV ).
Discussion
Our study has shown that particular dietary polyphenols are bioactive molecules that can inhibit the development of atherosclerosis. In particular, quercetin and theaflavin significantly attenuated lesion formation in ApoE Ϫ/Ϫ mice. Previous studies have shown that polyphenol-rich beverages, such as red wine, 21 dealcoholized red wine, 22 and tea, 27 can inhibit atherosclerosis in ApoE Ϫ/Ϫ mice. These beverages contain a complex mixture of polyphenolic compounds. Our study suggests that certain individual polyphenols can attenuate atherosclerosis, and these compounds may represent some of the active components of polyphenol-rich beverages. Compounds such as quercetin and theaflavin, which inhibit atherosclerosis, may do so through many pathways, including inhibition of inflammation (LTB 4 ), improvement of NO bioavailability, and propagation of HO-1 expression (Table) .
Lipid peroxidative damage may be a critical step in the pathogenesis of atherosclerosis. 2 The well-recognized antioxidant activity of many polyphenols has led to the proposal that polyphenol protection against atherosclerosis may involve their antioxidant properties. 28 Quercetin and catechins in red wine and tea have been shown to inhibit atherosclerosis Ϫ/Ϫ mice, expressed per unit mass of aortic arachidonic acid, after 20 weeks of different dietary treatments: C57BL/control (nϭ20), ApoE/ control (nϭ19), ApoE/quercetin (nϭ18), ApoE/(Ϫ)-epicatechin (nϭ18), ApoE/theaflavin (nϭ19), ApoE/sesamin (nϭ18), and ApoE/chlorogenic acid (nϭ18). B, Superoxide anion radical production in abdominal aortic tissues from C57BL and ApoE Ϫ/Ϫ mice after 20 weeks of different dietary treatments: C57BL/control (nϭ20), ApoE/control (nϭ19), ApoE/quercetin (nϭ19), ApoE/(Ϫ)-epicatechin (nϭ18), ApoE/theaflavin (nϭ20), ApoE/sesamin (nϭ18), and ApoE/chlorogenic acid (nϭ19). C, Ex vivo LTB 4 production in abdominal aortic tissues from C57BL and ApoE Ϫ/Ϫ mice after 20 weeks of different dietary treatments: C57BL/control (nϭ20), ApoE/control (nϭ20), ApoE/quercetin (nϭ19), ApoE/(Ϫ)-epicatechin (nϭ19), ApoE/theaflavin (nϭ20), ApoE/sesamin (nϭ19), and ApoE/chlorogenic acid (nϭ18). D, Plasma sP-selectin concentrations of C57BL and ApoE Ϫ/Ϫ mice (M creatinine) after 20 weeks (mice aged 26 weeks) of different dietary treatments: C57BL/control (nϭ20), ApoE/control (nϭ20), ApoE/quercetin (nϭ19), ApoE/(Ϫ)-epicatechin (nϭ19), ApoE/theaflavin (nϭ20), ApoE/sesamin (nϭ18), and ApoE/chlorogenic acid (nϭ18). In A through D, bars with the same subscript are not significantly different from each other using 1-way ANOVA analysis with the Tukey honestly significant difference post hoc analysis.
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in ApoE Ϫ/Ϫ mice while also reducing LDL susceptibility to oxidation. 27, 29 Quercetin-3-O-glucuronide (a major in vivo quercetin metabolite) was shown to localize within activated macrophages in human atherosclerotic lesions and to prevent the uptake of oxidized LDL through the downregulation of scavenger receptors. 30 Black tea consumption decreased lipoprotein oxidation in New Zealand white rabbits 31 ; and theaflavin, a major polyphenol present in black tea, was shown to be as effective as catechins as in vitro antioxidants. 16 The ingestion of sesame (in which sesamin is a major lignan) affected antioxidant status and reduced lipids in postmenopausal women. 17 Chlorogenic acid and its major in vivo metabolite, caffeic acid, have antioxidant effects in vitro, 32 whereas the consumption of coffee (a major dietary source of chlorogenic acid) resulted in the incorporation of phenolic acids into LDL and increased the resistance of LDL to ex vivo oxidation. 33 The polyphenols tested in our study were incorporated into the diet and given at a dose corresponding to achievable human intake. Oxidative stress in the vasculature was effectively attenuated by quercetin, as demonstrated by significant reduction of aortic F 2 -isoprostanes and superoxide (Figure 4) . Similarly, (Ϫ)-epicatechin also significantly decreased aortic F 2 -isoprostanes and superoxide. However, in the case of this polyphenol, inhibition of oxidative stress in the vessel was not associated with a significant reduction in aortic lesion size. Furthermore, theaflavin significantly attenuated atherosclerosis but did not significantly reduce vascular F 2 -isoprostanes and superoxide. Therefore, the inhibition of oxidative stress is not generally sufficient, nor is it a necessity, for polyphenols to inhibit atherosclerosis in ApoE Ϫ/Ϫ mice. This interpretation is consistent with the overall weak correlations between lesion size and markers of oxidative stress in the present study, in previous reports 2,21,22,34,35 of a dissociation of atherosclerosis and arterial lipoprotein lipid oxidation and oxidative stress in apoE Ϫ/Ϫ mice, and in other experimental models.
Hypercholesterolemia is well established as a risk factor for atherosclerosis, and it is possible that dietary polyphenols may protect against the disease by exerting hypocholesterolemic effects. However, animal and clinical studies 21, 36 are not conclusive. The polyphenols used in our study had no significant effect on plasma total cholesterol concentrations or lipoprotein distribution. This result is consistent with previous studies 21, 22, 28 in the ApoE Ϫ/Ϫ mouse. The absence of hypocholesterolemic activity suggested that the observed antiatherogenic effects of quercetin and theaflavin were independent of serum cholesterol in this study.
Leukocyte adhesion to endothelial cells and their subsequent infiltration into subendothelial spaces are mediated by various adhesion molecules, such as P-selectin and vascular cell adhesion molecule-1, which are expressed on leukocytes, platelets, and endothelial cells. 1 Plasma sP-selectin levels associated with preclinical atherosclerosis in hypercholesterolemic men, 37 and elevated plasma levels of sP-selectin were reported in high-risk patients with hypercholesterolemia 38 and hypertension. 39 ApoE Ϫ/Ϫ mice have significantly higher plasma concentrations of sP-selectin than C57BL/6J control mice. 40 In our study, dietary treatment with quercetin and theaflavin significantly lowered plasma sP-selectin ( Figure  4D ), suggesting that decreasing P-selectin expression may contribute to inhibition of atherogenesis in the ApoE Ϫ/Ϫ mouse by polyphenols. However, (Ϫ)-epicatechin also lowered sP-selectin yet did not significantly decrease atherosclerosis at either the aortic root or the thoracic aorta, indicating that inhibition of P-selectin expression may not be sufficient for polyphenols to inhibit atherosclerosis.
Inflammation is recognized as a key process in atherogenesis. 1, 2 Inflammatory processes in the vascular wall may be mediated by a range of factors, such as cytokines, eicosanoids, and NO, which in turn modulate cellular signaling, cell growth, differentiation, and a variety of other cellular processes. There is evidence that LTB 4 , a potent chemotactic molecule, is involved in arterial leukocyte recruitment. 41 LTB 4 signaling through nuclear factor-B-dependent LTB1 receptors on vascular smooth muscle promotes atherosclerosis and intimal hyperplasia, 42 whereas knockdown of the BLT1 receptor has been shown to reduce lesion formation in 
ApoE
Ϫ/Ϫ mice. 43 Selected phenolic acids and some polyphenols have been shown to inhibit eicosanoid pathways. 12 It has previously been shown that quercetin and its in vivo metabolites are capable of inhibiting LTB 4 production in vitro in human neutrophils. 15 (minus)-Epicatechin and related flavonoids have been shown to inhibit the synthesis of proinflammatory cytokines in vitro. 44 Theaflavin protected against inflammation in mice by inhibiting arachidonic acid metabolism via both 5-lipoxygenase and cyclooxygenase pathways. 45 Sesamin inhibited lipopolysaccharide-induced interleukin 6 production by suppression of the p38 mitogen-activated protein kinase signal pathway and nuclear factor-B activation. 46 Our results showed that quercetin and theaflavin significantly inhibited the ex vivo production of proinflammatory LTB 4 in the vasculature of the ApoE Ϫ/Ϫ mice and were better inhibitors of vascular LTB 4 production than (Ϫ)-epicatechin and sesamin ( Figure 4C ). Chlorogenic acid had no effect on vascular LTB 4 production, although it has been reported to exhibit other anti-inflammatory properties in vitro. 47 The fact that both quercetin and theaflavin were also able to significantly inhibit lesion formation suggests that this anti-inflammatory property contributes to the antiatherogenic effect of these 2 polyphenols.
The endothelium regulates vascular tone by balancing the production of vasodilators, most important NO, and vasoconstrictors, such as ET-1. Disruption of this balance may result in endothelial dysfunction. 48 Polyphenol consumption may help to reverse endothelial dysfunction. 11, 49, 50 Oral administration of pure (Ϫ)-epicatechin to humans increased flowmediated dilation, closely emulating the short-term vascular effects of flavonol-rich cocoa. 9 It has been shown that quercetin and (Ϫ)-epicatechin (200 mg each) immediately augment NO status and reduce ET-1 production in healthy men. 14 Our data suggest that quercetin and theaflavin, in particular, may improve endothelial function by increasing eNOS activity and augmenting NO production, as indicated by increased urinary nitrate excretion, in ApoE Ϫ/Ϫ mice. Quercetin and (Ϫ)-epicatechin have been shown to increase eNOS activity in endothelial cells in vitro via the inhibition of NADPH oxidase. 51, 52 Although quercetin and (Ϫ)-epicatechin both significantly reduced urinary ET-1, only quercetin significantly inhibited lesion size in this model. Endothelin ET A receptor blockade has been shown to inhibit atherosclerosis in ApoE Ϫ/Ϫ mice fed a high-fat diet, 53 suggesting a role for ET-1 in this model. Unfortunately, we did not measure vascular ET-1 protein content in our study, which may have been a better marker than urinary excretion.
The attenuation of lesion formation in the quercetin-fed ApoE Ϫ/Ϫ mouse was associated with increased expression of HO-1 protein in aortic lesions. HO-1 is thought to play a key protective role in inflammatory atherosclerotic disease, 54 and inducers of HO-1 reduce lesion size in apoE Ϫ/Ϫ mice, 55 LDL receptor-deficient mice, 56 and rabbits. 57 Moreover, adenovirus-mediated overexpression of HO-1 decreases lesion size in ApoE Ϫ/Ϫ mice. 58 Several polyphenols, including curcumin and resveratrol, have been reported to induce HO-1 expression and activity in vitro, 59 -61 although we are not aware of any previous report showing in vivo HO-1 induction by a polyphenol in the context of atherosclerosis. The synthetic phenol probucol and its metabolites can induce HO-1 and may be the main mode of action for the protective effects of this compound against atherosclerotic disease. 54, 55 Interestingly, arterial induction of HO-1 can protect eNOS from oxidative inactivation, 62 and NO can induce HO-1, 63 so that the 2 pathways may interact with each other in providing protection against atherosclerosis by polyphenols and other compounds.
Our study showed that the extent of atherogenesis in ApoE Ϫ/Ϫ mice correlated most strongly with eNOS activity (RϭϪ0.67, PϽ0.001) and urinary nitrate (RϭϪ0.52, PϽ0.001), consistent with the notion that NO bioavailability plays an important role in atherogenesis. This may explain why quercetin and theaflavin protected against atherosclerosis, whereas (Ϫ)-epicatechin did not, even though the latter showed significant antioxidant actions (Table) . Although some of this evidence relies on correlation data, more detailed studies will be required to establish a mechanistic link to atherogenesis.
We have shown that certain dietary polyphenols may have a range of bioactivities that contribute to the cardioprotective 
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effects of fruits, vegetables, red wine, and tea. Our results indicate that key dietary polyphenols, such as quercetin and theaflavin, may act to prevent atherosclerosis through a combination of effects, including the inhibition of inflammation, the stimulation of NO, and the induction of HO-1. This study had limitations. We chose a dose of each polyphenol compound that may represent a reasonable dietary intake and added each compound to the diet at the same concentration. This may not reflect the different dietary abundance of these compounds or differences in the bioavailability between the compounds. Future studies examining a dose-response for these compounds are required.
